Login to Your Account

Saniona partner starts phase III trial of weight loss drug

By Michael Fitzhugh
Staff Writer

Monday, August 21, 2017

Productos Medix S.A. de C.V., a Mexican weight loss specialist leading the most advanced effort to date to get Danish drug developer Saniona AB's first product to market, started a phase III trial of the drug, tesofensine, in obesity.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription